Management Team:

Board of Directors:

Christopher Cashman, Chairman


Mr. Cashman is currently Chairman and CEO of Marinus Pharmaceuticals, Inc and Chairman of Rapid Micro Biosystems. Prior to Marinus Chris co-founded Protez Pharmaceuticals and served as Director, President and CEO. Protez was acquired by Novartis in 2008. Chris also serves on the board of directors of Noble Biomaterials, MBF Therapeutics, Mid-Atlantic Diamond Ventures and the Science Center.

--Close Window--


Christopher Ragland

Thomas Tillett, President & CEO 

Clinical Advisory Board:

Corporate Counsel:

  • LinkedIn Classic
  • Facebook Classic
  • Twitter Social Icon

​Follow us at @mbftherapeutics

© 2020 MBF Therapeutics.   Advanced Immunotherapeutics for Life Sciences.  All rights reserved.